Article

Immune therapy produces anti-cancer effect in patients with RCC

A treatment approach that uses a donor's immune cells appears to provide anti-cancer activity in some patients with recurrent or refractory renal cell carcinoma, according to research published in the Journal of Clinical Oncology (2003; 21: 3785-91).

Newsletter

Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

© 2025 MJH Life Sciences

All rights reserved.